Reaction

Subdural Haemorrhage reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,719 reports · 61 co-occurring drugs

As of the last recalculation, Subdural Haemorrhage appears in 2,719 FAERS reports alongside 61 co-occurring drug terms. The strongest observed disproportionality signal is DABIGATRAN ETEXILATE MESYLATE (PRR 21.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dabigatran Etexilate Mesylate18921.321.4
Dabigatran Etexilate20021.221.3
Warfarin23715.615.6
Bleomycin Sulfate1914.214.2
Warfarin Sodium8213.913.9
Clopidogrel Bisulfate17413.813.9
Rivaroxaban31813.113.1
Trimethoprim1912.412.4
Prasugrel Hydrochloride1511.411.4
Apixaban9411.111.1
Fondaparinux Sodium1110.410.5
Clopidogrel2138.88.9
Dalteparin Sodium128.78.7
Alteplase178.78.7
Emicizumab148.78.7
Cefazolin108.48.4
Amlodipine Besylate And Valsartan106.96.9
Busulfan146.86.8
Lithium Carbonate156.86.8
Dronedarone96.86.8
Heparin Sodium126.76.7
Eplerenone116.66.6
Midazolam Hydrochloride236.66.6
Basiliximab106.56.5
Thiotepa86.46.4
Ibrutinib666.46.4
Cefazolin Sodium106.46.4
Phenobarbital126.46.4
Hydroxyurea176.26.2
Piperacillin And Tazobactam106.06.0
Piperacillin Sodium And Tazobactam Sodium155.95.9
Digoxin545.95.9
Midazolam195.85.8
Valganciclovir Hydrochloride Powder,95.75.7
Cytarabine435.65.6
Bisoprolol Fumarate955.55.5
Fludarabine Phosphate285.55.5
Cefepime105.45.4
Meropenem225.35.3
Febuxostat Tablets 40 Mg75.35.3
Febuxostat Tablets 80 Mg75.35.3
Isosorbide Mononitrate145.25.2
Blinatumomab75.15.1
Gefitinib65.15.1
Sotalol Hydrochloride115.15.1
Imatinib114.84.8
Cefepime Hydrochloride104.84.8
Bicalutamide94.54.5
Acalabrutinib74.44.4
Ticagrelor184.34.3
Etoposide384.04.0
Ifosfamide103.63.6
Romiplostim73.63.6
Azacitidine133.43.4
Axicabtagene Ciloleucel43.13.1
Dasatinib142.92.9
Derma Foam Excel Hand Sanitizer32.92.9
Ethanol32.92.9
Eltrombopag Olamine72.32.3
Ranibizumab82.32.3
Palivizumab42.02.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.